Genzyme will buy back $1.5b in stock
May 29, 2007 08:51 AM
E-mail|
|Comments
()|
Text size
–
+
Biotechnology company Genzyme Corp. said today that it will buy back up to $1.5 billion, or 20 million, of its shares over the next three years.
The company says the buyback should reduce dilution from its stock compensation programs and boost earnings per share. (AP)






